company background image
002437 logo

HARBIN GLORIA PHARMACEUTICALS XSEC:002437 Stock Report

Last Price

CN¥2.50

Market Cap

CN¥5.7b

7D

-12.9%

1Y

0.4%

Updated

23 Dec, 2024

Data

Company Financials

HARBIN GLORIA PHARMACEUTICALS Co., LTD

XSEC:002437 Stock Report

Market Cap: CN¥5.7b

002437 Stock Overview

Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China. More details

002437 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance2/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

HARBIN GLORIA PHARMACEUTICALS Co., LTD Competitors

Price History & Performance

Summary of share price highs, lows and changes for HARBIN GLORIA PHARMACEUTICALS
Historical stock prices
Current Share PriceCN¥2.50
52 Week HighCN¥2.99
52 Week LowCN¥1.66
Beta0.43
1 Month Change3.31%
3 Month Change31.58%
1 Year Change0.40%
3 Year Change-7.41%
5 Year Change-15.25%
Change since IPO-70.38%

Recent News & Updates

Recent updates

Shareholder Returns

002437CN PharmaceuticalsCN Market
7D-12.9%-3.1%-2.1%
1Y0.4%-4.4%9.8%

Return vs Industry: 002437 exceeded the CN Pharmaceuticals industry which returned -1.8% over the past year.

Return vs Market: 002437 underperformed the CN Market which returned 11.8% over the past year.

Price Volatility

Is 002437's price volatile compared to industry and market?
002437 volatility
002437 Average Weekly Movement8.3%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 002437 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002437's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20003,085Leifeng Guowww.gloria.cc

Harbin Gloria Pharmaceuticals Co., Ltd engages in the research, development, production, and sale of pharmaceutical products primarily in the People’s Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China.

HARBIN GLORIA PHARMACEUTICALS Co., LTD Fundamentals Summary

How do HARBIN GLORIA PHARMACEUTICALS's earnings and revenue compare to its market cap?
002437 fundamental statistics
Market capCN¥5.70b
Earnings (TTM)CN¥80.20m
Revenue (TTM)CN¥2.43b

71.1x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002437 income statement (TTM)
RevenueCN¥2.43b
Cost of RevenueCN¥1.12b
Gross ProfitCN¥1.31b
Other ExpensesCN¥1.23b
EarningsCN¥80.20m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.035
Gross Margin53.83%
Net Profit Margin3.30%
Debt/Equity Ratio2.3%

How did 002437 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:07
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HARBIN GLORIA PHARMACEUTICALS Co., LTD is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yalei YanBohai Securities Co., Ltd.
Shuchang LiuChangjiang Securities Co. LTD.
Shanshan LiChina Merchants Securities Co. Ltd.